SCHEMBL26423115

SCHEMBL26423115

Cc1ccc2c(c1)c(C(F)F)nn2C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.36
▸ KMT2A Q03164 3/20 0.36
▸ NR1I2 O75469 1/20 0.36
▸ AHR P35869 1/20 0.36
▸ ADORA2A P29274 1/20 0.36
▸ ADORA2B P29275 1/20 0.36
▸ NAMPT P43490 3/20 0.34
▸ KDM4E B2RXH2 8/20 0.32
▸ HSD17B10 Q99714 5/20 0.32
▸ HPGD P15428 4/20 0.32
▸ ALDH1A1 P00352 4/20 0.32
▸ GLA P06280 1/20 0.32
▸ ALOX15 P16050 1/20 0.32
▸ GAA P10253 2/20 0.32
▸ MAPT P10636 5/20 0.32
▸ RXFP1 Q9HBX9 1/20 0.32
▸ BCHE P06276 1/20 0.31
▸ ACHE P22303 1/20 0.31
▸ PARP15 Q460N3 1/20 0.31
▸ PARP14 Q460N5 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26433310 0.87 MEN1 (0.35) MEN1KMT2ANR1I2AHRADORA2A
SCHEMBL12123801 0.84 MAPK8 (0.38) MEN1KMT2ANR1I2AHRADORA2A
SCHEMBL30856573 0.81 PRKCI (0.36) MEN1KMT2AADORA2AADORA2BKDM4E
SCHEMBL31482837 0.81 MAPK8 (0.39) ADORA2AADORA2BMAPTLMNAHTT
SCHEMBL31482839 0.81 MAPK8 (0.39) ADORA2AADORA2BMAPTLMNAHTT
SCHEMBL26262738 0.79 HTR1D (0.38) MEN1KMT2AADORA2AADORA2BHSD17B10
SCHEMBL25975944 0.77 ADORA2A (0.39) MEN1KMT2ANR1I2AHRADORA2A
SCHEMBL29301506 0.76 HCAR3 (0.47) KDM4EHPGDALDH1A1RORC
SCHEMBL30147683 0.76 HCAR3 (0.47) KDM4EHPGDALDH1A1RORC
SCHEMBL29301503 0.76 ALDH1A1 (0.41) MEN1KMT2AKDM4EHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230312481-A1 SUBSTITUTED (PHTHALAZIN-1-YLMETHYL)UREAS, SUBSTITUTED N-(PHTHALAZIN-1-YLMETHYL)AMIDES, AND ANALOGUES THEREOF ARBUTUS BIOPHARMA CORP (CA) 2023-10-05 — — US disclosed
US-20230312481-A1 SUBSTITUTED (PHTHALAZIN-1-YLMETHYL)UREAS, SUBSTITUTED N-(PHTHALAZIN-1-YLMETHYL)AMIDES, AND ANALOGUES THEREOF ARBUTUS BIOPHARMA CORP (CA) 2023-10-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230312481-A1 SUBSTITUTED (PHTHALAZIN-1-YLMETHYL)UREAS, SUBSTITUTED N-(PHTHALAZIN-1-YLMETHYL)AMIDES, AND ANALOGUES THEREOF NSD3, PML, NSD1 MEN1 2151/4885KMT2A 201/4885NR1I2 250/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback